88 filings
6-K
CRDL
Cardiol Therapeutics Inc - Ordinary Shares
26 Feb 24
Material Change Report
10:06am
6-K
CRDL
Cardiol Therapeutics Inc - Ordinary Shares
21 Feb 24
Cardiol Therapeutics Completes Patient Enrollment in its Phase II
7:29am
6-K
CRDL
Cardiol Therapeutics Inc - Ordinary Shares
15 Feb 24
Cardiol Therapeutics Granted Orphan Drug Designation for its
7:30am
6-K
CRDL
Cardiol Therapeutics Inc - Ordinary Shares
24 Jan 24
Current report (foreign)
7:29am
6-K
CRDL
Cardiol Therapeutics Inc - Ordinary Shares
9 Jan 24
Cardiol Therapeutics Announces it has Exceeded
7:31am
6-K
0m2ievvk7de
5 Dec 23
MAvERIC-Pilot is a Phase II Study in Recurrent Pericarditis and is Anticipated to Complete Patient Recruitment during Q1 2024
7:30am
6-K
y3r5q1rbvat
16 Nov 23
Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group
6:01am
6-K
ecbfu 7dr
14 Nov 23
Current report (foreign)
4:42pm
6-K
9v5njldrb 2sn2itft
1 Nov 23
Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its
7:29am
6-K
lwe4rzc8dkgq8cgee 2x
20 Oct 23
Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
5:01pm
6-K
nr8qj s3x84c
11 Oct 23
Material Change Report
10:00am
6-K
ugrhzbdjtnpz994
10 Oct 23
Data Presented at the Heart Failure Society of America Annual Scientific Meeting 2023
6:01am
6-K
vb114nn 8ifme7sm46
26 Sep 23
Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference
7:28am
6-K
8csylt
20 Sep 23
Material Change Report
10:00am
6-K
s02l8wet
19 Sep 23
Recruitment Accelerating and Full Patient Enrollment Anticipated to be Completed During Q3 2024, up to Six Months Ahead of Schedule
7:29am
6-K
a1nmzcbqt6brxnht2
10 Aug 23
Current report (foreign)
5:13pm
6-K
21gb ceog4p4uyd
9 Aug 23
Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
8:21am
6-K
s9zu okvf71f6
8 Aug 23
Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market
7:38am
6-K
klkw 3r9y
29 Jun 23
Cardiol Therapeutics Reports Results of 2023 Annual General Meeting
11:44am
6-K
dfkb7rtc
27 Jun 23
Current report (foreign)
7:28am